期刊
CELLS
卷 6, 期 4, 页码 -出版社
MDPI
DOI: 10.3390/cells6040042
关键词
adrenocortical carcinoma (ACC); proline glutamic acid and leucine rich protein 1 (PELP1); estrogen receptor alpha (ER alpha); insulin growth factor-1 receptor (IGF1R); insulin-like growth factor II (IGF-II)
类别
资金
- Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG10344, IG14433]
- Fondo Investimenti Ricerca di Base (FIRB) Accordi di Programma from the Ministry of Education, University and Research, Rome, Italy [RBAP1153LS-02]
PELP1 acts as an estrogen receptor (ER) coactivator that exerts an essential role in the ER's functions. ER coregulators have a critical role in the progression and response to hormonal treatment of estrogen-dependent tumors. We previously demonstrated that, in adrenocortical carcinoma (ACC), ER alpha is upregulated and that estradiol activates the IGF-II/IGF1R signaling pathways defining the role of this functional cross-talk in H295R ACC cell proliferation. The aim of this study was to determine if PELP1 is expressed in ACC and may play a role in promoting the interaction between ER alpha and IGF1R allowing the activation of pathways important for ACC cell growth. The expression of PELP1 was detected by Western blot analysis in ACC tissues and in H295R cells. H295R cell proliferation decrease was assessed by A3-(4,5-Dimethylthiaoly)-2,5-diphenyltetrazolium bromide (MTT) assay and [3H] thymidine incorporation. PELP1 is expressed in ACC tissues and in H295R cells. Moreover, treatment of H295R with E2 or IGF-II induced a multiprotein complex formation consisting of PELP1, IGF1R, ER alpha, and Src that is involved in ERK1/2 rapid activation. PELP1/ER/IGF1R/c-Src complex identification as part of E2- and IGF-II-dependent signaling in ACC suggests PELP1 is a novel and more efficient potential target to reduce ACC growth.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据